Correlation Between Neovacs SA and Spineguard

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neovacs SA and Spineguard at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neovacs SA and Spineguard into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neovacs SA and Spineguard, you can compare the effects of market volatilities on Neovacs SA and Spineguard and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neovacs SA with a short position of Spineguard. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neovacs SA and Spineguard.

Diversification Opportunities for Neovacs SA and Spineguard

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Neovacs and Spineguard is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Neovacs SA and Spineguard in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spineguard and Neovacs SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neovacs SA are associated (or correlated) with Spineguard. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spineguard has no effect on the direction of Neovacs SA i.e., Neovacs SA and Spineguard go up and down completely randomly.

Pair Corralation between Neovacs SA and Spineguard

Assuming the 90 days trading horizon Neovacs SA is expected to generate 38.24 times less return on investment than Spineguard. In addition to that, Neovacs SA is 2.63 times more volatile than Spineguard. It trades about 0.0 of its total potential returns per unit of risk. Spineguard is currently generating about 0.12 per unit of volatility. If you would invest  13.00  in Spineguard on September 24, 2024 and sell it today you would earn a total of  8.00  from holding Spineguard or generate 61.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Neovacs SA  vs.  Spineguard

 Performance 
       Timeline  
Neovacs SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neovacs SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Neovacs SA is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Spineguard 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Spineguard are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Spineguard reported solid returns over the last few months and may actually be approaching a breakup point.

Neovacs SA and Spineguard Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neovacs SA and Spineguard

The main advantage of trading using opposite Neovacs SA and Spineguard positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neovacs SA position performs unexpectedly, Spineguard can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spineguard will offset losses from the drop in Spineguard's long position.
The idea behind Neovacs SA and Spineguard pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance